The future of fibroid therapy

Elizabeth A Stewart, Adriana Faur

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

While medical and surgical treatment are the mainstays of therapy today, advances in molecular biology and genetics promise to dramatically change the ob/gyn's approach to these common tumors. TAP pharmaceuticals.

Original languageEnglish (US)
Pages (from-to)26-38
Number of pages13
JournalContemporary Ob-Gyn
Volume45
Issue number7
StatePublished - 2000
Externally publishedYes

Fingerprint

Leiomyoma
Molecular Biology
Therapeutics
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

The future of fibroid therapy. / Stewart, Elizabeth A; Faur, Adriana.

In: Contemporary Ob-Gyn, Vol. 45, No. 7, 2000, p. 26-38.

Research output: Contribution to journalArticle

Stewart, EA & Faur, A 2000, 'The future of fibroid therapy', Contemporary Ob-Gyn, vol. 45, no. 7, pp. 26-38.
Stewart, Elizabeth A ; Faur, Adriana. / The future of fibroid therapy. In: Contemporary Ob-Gyn. 2000 ; Vol. 45, No. 7. pp. 26-38.
@article{c2f13f7fd8e046fbac3672e5ed833c0b,
title = "The future of fibroid therapy",
abstract = "While medical and surgical treatment are the mainstays of therapy today, advances in molecular biology and genetics promise to dramatically change the ob/gyn's approach to these common tumors. TAP pharmaceuticals.",
author = "Stewart, {Elizabeth A} and Adriana Faur",
year = "2000",
language = "English (US)",
volume = "45",
pages = "26--38",
journal = "Contemporary Ob/Gyn",
issn = "0090-3159",
publisher = "Advanstar Communications",
number = "7",

}

TY - JOUR

T1 - The future of fibroid therapy

AU - Stewart, Elizabeth A

AU - Faur, Adriana

PY - 2000

Y1 - 2000

N2 - While medical and surgical treatment are the mainstays of therapy today, advances in molecular biology and genetics promise to dramatically change the ob/gyn's approach to these common tumors. TAP pharmaceuticals.

AB - While medical and surgical treatment are the mainstays of therapy today, advances in molecular biology and genetics promise to dramatically change the ob/gyn's approach to these common tumors. TAP pharmaceuticals.

UR - http://www.scopus.com/inward/record.url?scp=0004985423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0004985423&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0004985423

VL - 45

SP - 26

EP - 38

JO - Contemporary Ob/Gyn

JF - Contemporary Ob/Gyn

SN - 0090-3159

IS - 7

ER -